EPAM up +1.87% percent right now. $EPAM High is at 47.86

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
EPAM up +1.87% percent right now. $EPAM High is at 47.86 and the Low 46.82 with current volume of 92,186.

Recent News posted below.

EPAM Epam Systems Inc Recent Headline News

EPAM Recognized as a Global R&D and Product Development Services Leader for Enterprise Software and Consumer Software Markets
Thomson Reuters ONE - Tue Nov 11, 8:01AM CST
Newtown, PA - November 11, 2014 - EPAM (NYSE:EPAM), a leading provider of product development and software engineering solutions, today announced it has been recognized by Zinnov management consulting firm as one of the leaders in 2 Software Product Development verticals: Consumer Software and Enterprise Software.
EPAM: 47.83 (+0.85)

Stocks Turn Mixed; Epam Bounces Back
at Investor's Business Daily - Tue Nov 04, 2:13PM CST
Stocks continued to improve late Tuesday, turning mixed. The Dow Jones industrial average bounced back from a 0.5% loss and was up a fraction. The broader Nasdaq and the S&P 500 were off 0.4% each. They had been off 0.9% and 0.8%, respectively. NYSE...
FEYE: 32.68 (+0.29), AWAY: 30.68 (+1.02), FRGI: 55.82 (-0.69), SAVE: 78.75 (-0.30), LNKD: 229.86 (+0.61), SCTY: 50.03 (-1.75), STE: 64.27 (+0.63), PZZA: 49.89 (-0.52), JAZZ: 171.52 (-2.91), FL: 54.57 (-0.20), EPAM: 47.83 (+0.85)

EPAM Systems' (EPAM) CEO Arkadiy Dobkin on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 1:13PM CST

EPAM: 47.83 (+0.85)

Epam beats Street 3Q forecasts
Automated Insights - Mon Nov 03, 6:42PM CST
NEWTOWN, Pa. (AP) _ Epam Systems Inc. (EPAM) on Monday reported third-quarter profit of $19 million.
EPAM: 47.83 (+0.85)

EPAM Systems beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:15PM CST

EPAM: 47.83 (+0.85)

EPAM Systems Reports Results for Third Quarter 2014
Thomson Reuters ONE - Mon Nov 03, 5:04PM CST
Third Quarter Revenues Up 38% Year-Over-Year and 10% Sequentially
EPAM: 47.83 (+0.85)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST

RKT: 55.99 (-0.10), HLF: 37.47 (-0.67), EGAN: 5.34 (-0.21), CUTR: 10.69 (-0.10), DXPE: 67.01 (-0.65), AEIS: 20.59 (-0.20), NOR: 4.09 (+0.04), KBR: 19.08 (-0.01), SGY: 22.80 (+1.03), RTEC: 9.11 (-0.09), PKT: 7.00 (-0.25), OGS: 39.03 (-0.22), BKH: 56.37 (-0.49), KAMN: 41.00 (-0.44), EOX: 2.98 (unch), MR: 30.56 (-0.04), RKUS: 12.72 (+0.18), LCI: 50.03 (-1.78), NBIX: 19.10 (+0.12), PQ: 4.00 (+0.10), RBC: 71.17 (+0.39), CHGG: 6.97 (+0.04), AIG: 54.49 (+0.13), MRO: 33.36 (+0.11), GRT: 13.91 (unch), EPAM: 47.83 (+0.85), CKP: 13.16 (+0.30), SBRA: 27.98 (-0.54), MDU: 25.65 (-0.30), NTRI: 17.90 (-0.02), ELNK: 4.43 (+0.09), EQC: 25.92 (-0.06), CVD: 100.45 (-0.42), IART: 47.37 (-0.01), FN: 17.64 (-0.09), APL: 33.44 (-0.61), BDE: 8.45 (+0.09), AGU: 98.76 (+0.88), PLOW: 22.94 (-0.40), REG: 62.19 (+0.09), QLYS: 35.91 (-0.09), GALE: 1.95 (+0.02), ANV: 1.16 (+0.06), ININ: 47.76 (-0.31), FTR: 6.51 (+0.01), GTY: 18.73 (-0.02), MCEP: 16.44 (-1.55), CYH: 48.52 (+0.40), SKH: 6.95 (-0.15), ACXM: 19.09 (-0.12), PL: 69.81 (+0.10), RLD: 11.51 (-0.04), CXW: 36.37 (-0.37), SALE: 14.60 (-0.32), ENH: 57.78 (+0.24), CRK: 11.93 (+0.67), AMTG: 16.30 (-0.08), OTTR: 31.22 (-0.02), NLS: 14.50 (-0.20)

Stocks End Week On Fine Note; LinkedIn Surges On Earnings
at Investor's Business Daily - Fri Oct 31, 3:29PM CDT
The market enjoyed another shot of institutional buying Friday, cheered by additional -- and unexpected -- stimulus measures by the Bank of Japan. Another round of healthy earnings reports and a rise in U.S. consumer confidence also fueled positive...
AMBA: 49.19 (-0.02), TSLA: 250.21 (+8.28), GPRO: 74.41 (-1.34), ACT: 243.08 (-2.65), FRGI: 55.82 (-0.69), LNKD: 229.86 (+0.61), JAZZ: 171.52 (-2.91), FLT: 148.35 (-1.55), EPAM: 47.83 (+0.85), REGN: 397.90 (+11.93), BABA: 115.02 (-4.13)

EPAM Acquires Great Fridays, Expands Product and Service Design Capabilities
Thomson Reuters ONE - Fri Oct 31, 11:15AM CDT
Newtown, PA -October 31, 2014 - EPAM (NYSE:EPAM), a leading provider of product development and software engineering solutions, today announced its acquisition of Great Fridays Ltd., a product and service design group.
EPAM: 47.83 (+0.85)

Technology Outsourcer Epam Systems Knows The Big Deal
at Investor's Business Daily - Wed Oct 29, 5:12PM CDT
After spending most of its 21 years going after smaller contracts and growing them into much larger ones, Epam Systems is aiming for bigger game. The company, founded in 1993, provides outsourced software engineering and other IT services to clients...
BCS: 14.95 (+0.08), HP: 86.50 (+0.10), UBS: 17.32 (+0.21), INFY: 67.14 (-0.62), CTSH: 52.94 (-0.71), EPAM: 47.83 (+0.85)

EPAM Systems, Inc. (EPAM) in Focus: Stock Rises 5.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 8:32AM CDT
EPAM Systems, Inc. (EPAM) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
CUDA: 34.86 (+1.71), FICO: 71.73 (+1.00), UIS: 27.66 (+0.29), EPAM: 47.83 (+0.85)

Stocks Hold Modestly Lower; AmerisourceBergen Breaks Out
at Investor's Business Daily - Mon Oct 27, 12:18PM CDT
Stocks were off their session lows, but still modestly lower Monday afternoon. The Nasdaq and the S&P 500 were off by 0.1% and 0.3%, respectively. Both had been down as much as 0.7% intraday. The Dow Jones industrial average fell 0.2%. Volume was...
ABC: 88.00 (+0.29), GPRO: 74.41 (-1.34), EXP: 88.43 (+0.54), EPAM: 47.83 (+0.85)

InsiderInsights.com Daily Round Up 10/24/14: AGCO, BDBD, SABA
InsiderInsights - at Seeking Alpha - Mon Oct 27, 1:55AM CDT

BTUI: 3.28 (+0.05), HON: 96.90 (-0.37), RDEN: 18.61 (+0.24), AGCO: 45.18 (-0.06), AMS: 2.43 (-0.01), BBY: 34.67 (-0.04), RGLS: 20.02 (-0.89), LAWS: 22.20 (-0.26), HMTV: 12.75 (-0.15), NLNK: 32.68 (-1.72), BDBD: 9.15 (-0.10), COST: 136.96 (-0.73), TLLP: 56.96 (-0.60), EPAM: 47.83 (+0.85), CRM: 63.86 (-0.59)

Will Epam Systems Engineer A Successful Breakout?
at Investor's Business Daily - Fri Oct 24, 6:06PM CDT
Epam Systems is a software engineering and IT services firm that competes with outsourcing companies in China and India. While it's headquartered in Pennsylvania, the bulk of its workforce is in Central and Eastern Europe. As noted in IBD's IPO...
EPAM: 47.83 (+0.85)

Nascent Rally Gains Traction; Caterpillar, 3M Boost Dow
at Investor's Business Daily - Thu Oct 23, 1:58PM CDT
Major averages showed broad gains and were near session highs with a little more than one hour remaining in Wednesday's session. The Nasdaq jumped 2.1% and the S&P 500 and Dow Jones industrial average gained 1.8% each. The Dow was helped by strong...
AMZN: 310.56 (+5.45), LCI: 50.03 (-1.78), MMM: 156.71 (-0.95), AAP: 144.42 (-0.75), ORLY: 179.25 (-0.84), CAT: 102.42 (+0.21), EPAM: 47.83 (+0.85), CERN: 62.85 (-0.57)

Stocks Hold Big Gains; Tyler, Epam Break Out
at Investor's Business Daily - Thu Oct 23, 12:32PM CDT
Stocks remained firmly higher in early afternoon trading Thursday as more highly rated names staged breakouts. The Nasdaq led the way, up 1.6%, while the Dow Jones industrial average rose 1.4% and the S&P 500 added 1.3%. Volume was tracking mixed in...
KMX: 55.70 (-0.38), UA: 67.94 (-0.40), TYL: 109.74 (-0.30), EPAM: 47.83 (+0.85), BABA: 115.01 (-4.14)

EPAM Systems, Inc. Announces Date for Third-Quarter 2014 Earnings Release and Conference Call
Thomson Reuters ONE - Fri Oct 17, 3:25PM CDT
Newtown, PA - October 17, 2014 - EPAM Systems, Inc. (NYSE: EPAM), a leading provider of complex software engineering solutions and a leader in Central and Eastern European IT service delivery, today announced plans to release its third-quarter 2014 results after the market closes on Monday, November 3, 2014. The Company will host a conference call to discuss results on Tuesday, November 4, 2014 at 8:00 a.m. Eastern Time. The live conference call can be accessed by dialing 1-877-407-0784 (international) or 1-201-689-8560 (domestic).
EPAM: 47.83 (+0.85)

Stocks Trim Opening Losses; Netflix Crumbles, Delta Jumps
at Investor's Business Daily - Thu Oct 16, 9:40AM CDT
Stocks opened lower, then quietly whittled losses Thursday. The Nasdaq was down 1.5%, up from a nearly 2% drop at the open. The Dow Jones industrial average showed a 0.5% loss and the S&P 500 was down 0.6%. Trade was quiet on both the Nasdaq and the...
NFLX: 386.54 (-0.73), GS: 191.85 (+0.05), DAL: 43.78 (+0.41), EXPE: 86.41 (+0.41), EPAM: 47.83 (+0.85)

EPAM Recognized among Top 10 Largest Commerce Service Providers by Leading Independent Research Firm
Thomson Reuters ONE - Fri Oct 10, 8:00AM CDT
Newtown, PA - October 10, 2014 - EPAM (NYSE:EPAM) has been included in the list of the top 10 largest commerce service providers in Forrester Research, Inc.'s September, 2014 "Commerce Service Providers Market Overview: Large Scale Partners Can Accelerate Commerce For Key Customers" report. The report reviewed over 110 responses from representatives at both leading full-line and specialty CSP companies, and details the eCommerce platforms, geographies, and industry verticals that the largest CSPs support.
FORR: 40.39 (-0.31), EPAM: 47.83 (+0.85)

Epam Systems Back In Rally Mode After Recent Pullback
at Investor's Business Daily - Wed Oct 08, 3:28PM CDT
Sometimes, a stock's base-building effort runs into trouble. That's what happened to Epam Systems (EPAM) in July when its cup-with-handle pattern went wrong. A modest decline in the handle turned into a 20% pullback -- too steep to be a proper...
EPAM: 47.83 (+0.85)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading